scholarly journals Prevalence of Gynecological Disorders of Goat and Pattern of Drug used at Chuadanga, Bangladesh

Author(s):  
Md. Abu Sayeed ◽  
Mst. Sawda Khatun ◽  
Md. Saiful Bari ◽  
Amith Kumar Dash ◽  
Prodip Kumar Haldar ◽  
...  

Background: Gynecological disorders are the major challenge for Goat production profitability in Chuadanga, a goat dominating district of Bangladesh. To control the gynecological cases of goats in Chuadanga district, it is of utmost importance to estimate the prevalence of them along with their current therapeutic management. Methods: A cross sectional study was conducted from May, 2018 to April, 2019 on a total of 89 gynecological cases of goat to estimate the prevalence of different gynecological disorders along with drug prescribing patterns at Chuadanga Sadar Upazilla, Chuadanga, Bangladesh. Relevant data on different gynecological cases of goat were collected from the registered sheets of Upazilla Veterinary Hospital (UVH) and used for this study. Result: The highest prevalence of gynecological case was of anoestrous (20.2%) followed by abortion (18.0%), retained placenta (16.9%), pyometra (10.1%), dystocia (9.0%), repeat breeding (6.7%) and prolapse of the vagina (5.6%). The prevalence of metritis was 4.5% followed by milk fever (4.5%), prolapse of the rectum (3.4%) and postpartum bleeding (1.1%). Prostaglandin (25.0%) followed by a combination of oxytocin and calcium (18.8%) and combination of oxytetracycline and metronidazole (18.8%) were commonly prescribed drugs for treating abortion cases. Vitamin AD3E (33.3%) was prescribed the highest for treating anoestrous. A combination of oxytocin and oxytetracycline (33.3%), followed by oxytocin (26.6%) were predominantly prescribed for treating retained placenta. This study reveals the overall burden of reproductive disorders of goat along with drug prescribing patterns at the Chuadanga, Bangladesh. This outcome will be supportive to know the better treatment strategy against reproductive disorders in goat.

1978 ◽  
Vol 7 (2) ◽  
pp. 74-82 ◽  
Author(s):  
L. J. CHRISTOPHER ◽  
B. R. BALLINGER ◽  
A. M. M. SHEPHERD ◽  
A. RAMSAY ◽  
G. CROOKS

2011 ◽  
Vol 24 (6) ◽  
pp. 647-653 ◽  
Author(s):  
Jesper Rømhild Davidsen ◽  
Jesper Hallas ◽  
Jens Søndergaard ◽  
René dePont Christensen ◽  
Hans Christian Siersted ◽  
...  

2021 ◽  
Vol Volume 14 ◽  
pp. 4155-4168
Author(s):  
Montserrat Viñas-Bastart ◽  
Míriam Oms-Arias ◽  
Àfrica Pedraza-Gutiérrez ◽  
Irene Lizano-Díez ◽  
Eduardo L Mariño ◽  
...  

Author(s):  
Nehad Ahmed ◽  
Ziyad S. Almalki ◽  
Mohammed Alhajri ◽  
Abdulrahman Alharbi

Aim: This study aimed to analyze acyclovir prescription patterns in a public hospital in AlKharj. Methodology: Cross-sectional study, via hospital pharmacy services that included collecting data on acyclovir utilization from de-identified pharmacy records in maternity and children hospital in Alkharj from 1 Jan 2018 until 31 Aug 2020. Results: A total of 1059 prescriptions contained acyclovir were dispensed between 1 Jan 2018 till 31 Aug 2020. In the present study, acyclovir was prescribed mainly as an intravenous (45.89%) or oral (34.09%) treatment. It is prescribed mainly as a vial (45.89%) followed by suspension (31.63%). Inpatient Ward prescribed 52.60% of the prescriptions and emergency department prescribed 25.87% of the prescriptions. Conclusion: It can be concluded that acyclovir was prescribed commonly in the hospital and that it’s using should be monitored to ensure that it is prescribed and dispensed appropriately.


Author(s):  
Blaire M White ◽  
Sarah L Anderson ◽  
Joel C Marrs

Abstract Purpose The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to treat hypertension (HTN) during pregnancy presents well-established risks to a developing fetus. A cross-sectional study was conducted to evaluate the current state of antihypertensive prescribing and contraceptive use in females of childbearing age within a large safety-net health system. Methods The retrospective cross-sectional study focused on females aged 18-49 years with a documented diagnosis of HTN. The proportion of patients prescribed an ACE inhibitor or ARB and using a documented form of contraception was calculated. Documented forms of contraception included oral contraceptives, intrauterine devices, injections, implants, and surgical intervention. Results A total of 4,187 patients were identified from the HTN registry; after application of exclusion criteria 3,045 patients were included in the study population. The mean age was 39 years (range, 18-49 years). The most frequently prescribed classes of antihypertensive medications were ACE inhibitors and ARBs (one or the other was used by 1,146 patients [37.6%]), followed by thiazide diuretics (n = 710, 23.3%) and calcium channel blockers (n = 599, 19.7%). Of the 1,146 patients prescribed an ACE inhibitor or ARB, 553 (48%) were using a documented form of contraception. Conclusion Rates of ACE inhibitor or ARB prescribing to females of childbearing age were high despite the teratogenic risks, and fewer than half of patients had documented protection from pregnancy. Provider and patient education and potential creation of best practice alerts in the electronic medical record regarding the risks of using ACE inhibitors and ARBs in females of childbearing age are warranted.


Sign in / Sign up

Export Citation Format

Share Document